PEOPLE - Dyax makes appointment:
This article was originally published in Clinica
Executive Summary
Pamela Hay has been promoted to senior vice-president, corporate development, of Dyax. The US company develops therapeutic and diagnostic products using its phage display technology, an extremely sensitive means of identifying and separating molecules which have specific binding or high affinity properties.